ATE509632T1 - Behandlung von entzündlicher darmerkrankung - Google Patents
Behandlung von entzündlicher darmerkrankungInfo
- Publication number
- ATE509632T1 ATE509632T1 AT03750165T AT03750165T ATE509632T1 AT E509632 T1 ATE509632 T1 AT E509632T1 AT 03750165 T AT03750165 T AT 03750165T AT 03750165 T AT03750165 T AT 03750165T AT E509632 T1 ATE509632 T1 AT E509632T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- inflammatory bowel
- bowel disease
- methods
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002952084A AU2002952084A0 (en) | 2002-10-16 | 2002-10-16 | Treatment of inflammatory bowel disease |
AU2003902452A AU2003902452A0 (en) | 2003-05-20 | 2003-05-20 | Treatment of inflammatory bowel disease |
PCT/AU2003/001365 WO2004035078A1 (en) | 2002-10-16 | 2003-10-15 | Treatment of inflammatory bowel disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE509632T1 true ATE509632T1 (de) | 2011-06-15 |
Family
ID=32108554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03750165T ATE509632T1 (de) | 2002-10-16 | 2003-10-15 | Behandlung von entzündlicher darmerkrankung |
Country Status (6)
Country | Link |
---|---|
US (2) | US7410945B2 (de) |
EP (1) | EP1558277B1 (de) |
JP (1) | JP4818726B2 (de) |
AT (1) | ATE509632T1 (de) |
CA (1) | CA2542507C (de) |
WO (1) | WO2004035078A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPS160602A0 (en) * | 2002-04-08 | 2002-05-16 | University Of Queensland, The | Therapeutic method |
AU2002952086A0 (en) * | 2002-10-16 | 2002-11-07 | The University Of Queensland | Treatment of osteoarthritis |
WO2004035078A1 (en) * | 2002-10-16 | 2004-04-29 | The University Of Queensland | Treatment of inflammatory bowel disease |
US7885748B2 (en) * | 2006-09-13 | 2011-02-08 | Gm Global Technology Operations, Inc. | Virtual accelerometer |
MX2010002712A (es) | 2007-09-10 | 2010-06-09 | Calcimedica Inc | Compuestos que modulan calcio intracelular. |
US8785374B2 (en) * | 2007-10-19 | 2014-07-22 | Alba Therapeutics Corporation | Inhibitors of mammalian tight junction opening |
JP2010043063A (ja) | 2008-05-09 | 2010-02-25 | Agency For Science Technology & Research | 川崎病の診断及び治療 |
EP2321303B1 (de) * | 2008-08-27 | 2019-11-27 | Calcimedica, Inc. | Verbindungen als modulatoren von intrazellulärem calcium |
US8524763B2 (en) * | 2008-09-22 | 2013-09-03 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
EP2477982A4 (de) | 2009-09-16 | 2013-04-03 | Calcimedica Inc | Verbindungen als modulatoren von intrazellulärem calcium |
WO2019075319A1 (en) * | 2017-10-12 | 2019-04-18 | Board Of Regents, The University Of Texas System | COMPOSITIONS AND METHODS FOR TREATING PAIN IN WOMEN |
CN116115582B (zh) * | 2022-11-10 | 2024-04-16 | 重庆大学 | 前药封装的工程化益生菌及其制备方法与应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807824A (en) * | 1993-12-06 | 1998-09-15 | Ciba-Geigy Corporation | C5A receptor antagonists having substantially no agonist activity |
CA2181787A1 (en) * | 1994-03-03 | 1995-09-08 | Claire M. Doerschuk | Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
US5614370A (en) * | 1994-03-18 | 1997-03-25 | Merck & Co., Inc. | Assay to identify human C5a antagonists and agonists |
AU6125096A (en) * | 1995-06-05 | 1996-12-24 | Novartis Ag | C5a receptor antagonists having substantially no agonist activity and methods for preparation |
SE9701219D0 (sv) * | 1997-04-04 | 1997-04-04 | Astra Pharma Prod | New compounds |
AUPO755097A0 (en) * | 1997-06-25 | 1997-07-17 | University Of Queensland, The | Receptor agonist and antagonist |
US6611377B1 (en) * | 2000-07-10 | 2003-08-26 | Intel Corporation | Micromechanical diffraction phase grating |
AUPR833401A0 (en) * | 2001-10-17 | 2001-11-08 | University Of Queensland, The | G protein-coupled receptor antagonists |
AUPS160602A0 (en) * | 2002-04-08 | 2002-05-16 | University Of Queensland, The | Therapeutic method |
AU2002952086A0 (en) * | 2002-10-16 | 2002-11-07 | The University Of Queensland | Treatment of osteoarthritis |
WO2004035078A1 (en) * | 2002-10-16 | 2004-04-29 | The University Of Queensland | Treatment of inflammatory bowel disease |
AU2003902586A0 (en) * | 2003-05-26 | 2003-06-12 | The University Of Queensland | Treatment of burns |
US7910945B2 (en) * | 2006-06-30 | 2011-03-22 | Cree, Inc. | Nickel tin bonding system with barrier layer for semiconductor wafers and devices |
-
2003
- 2003-10-15 WO PCT/AU2003/001365 patent/WO2004035078A1/en active Application Filing
- 2003-10-15 EP EP03750165A patent/EP1558277B1/de not_active Expired - Lifetime
- 2003-10-15 AT AT03750165T patent/ATE509632T1/de not_active IP Right Cessation
- 2003-10-15 CA CA2542507A patent/CA2542507C/en not_active Expired - Fee Related
- 2003-10-15 US US10/531,564 patent/US7410945B2/en not_active Expired - Fee Related
- 2003-10-15 JP JP2005501247A patent/JP4818726B2/ja not_active Expired - Fee Related
-
2008
- 2008-06-23 US US12/144,266 patent/US20090004264A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2542507C (en) | 2013-04-16 |
US20090004264A1 (en) | 2009-01-01 |
CA2542507A1 (en) | 2004-04-29 |
EP1558277B1 (de) | 2011-05-18 |
US20060135411A1 (en) | 2006-06-22 |
JP4818726B2 (ja) | 2011-11-16 |
WO2004035078A1 (en) | 2004-04-29 |
EP1558277A4 (de) | 2009-07-29 |
US7410945B2 (en) | 2008-08-12 |
JP2006505621A (ja) | 2006-02-16 |
EP1558277A1 (de) | 2005-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2340179T3 (es) | Antagonistas de urea del receptor p2y1 utiles en el tratamiento de afecciones tromboticas. | |
ATE509632T1 (de) | Behandlung von entzündlicher darmerkrankung | |
ATE556060T1 (de) | Monocyclische anilidspirohydantoine als cgrp- rezeptorantagonisten | |
ATE485269T1 (de) | C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden | |
CY1109487T1 (el) | Ανταγωνιστες τυπου ουριας του υποδοχεα p2y1 χρησιμοι στην αγωγη θρομβωτικων καταστασεων | |
EA200602062A1 (ru) | Амидосоединения и их применение в качестве фармацевтических средств | |
ATE535514T1 (de) | Carboxamid-spirohydantoin-cgrp-rezeptor- antagonisten | |
WO2007027761A3 (en) | Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease | |
TW200630096A (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
EP1017713A4 (de) | ZYKLISCHE AGONISTEN UND ANTAGONISTEN DER C5a REZEPTOREN SOWIE G-PROTEIN GEKOPPELTEN REZEPTOREN | |
DE602006020871D1 (de) | Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden | |
ATE493412T1 (de) | Spirohydantoin-aryl-cgrp-rezeptorantagonisten | |
DE602005023124D1 (de) | Spirobenzodioxole und deren verwendung als cb1-antagonisten | |
NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
UA96926C2 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
SG151283A1 (en) | Treatment of neurological conditions using complement c5a receptor modulators | |
MX2007003545A (es) | Composiciones y metodos para tratar trastornos cognitivos. | |
DE60314896D1 (de) | 5-ht 1b/1d rezeptor agonisten zur behandlung von kopfschmerz der aus der verabreichung von endothelin rezeptor antagonisten resultiert | |
HK1072012A1 (en) | 5-ht4 receptor antagonists for the treatment of heart failure | |
MX2007004461A (es) | Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico. | |
WO2008120263A3 (en) | Prokineticins receptors antagonists, derivatives and uses thereof | |
ITFI20030238A1 (it) | Peptidi ciclici antagonisti dell'urotensina-ii | |
NO20076387L (no) | Anvendelse av IL-18BP isoformer til behandling og/eller forhindring av neurologiske inflammatoriske sykdommer | |
WO2003106694A3 (en) | QUICK METHODS FOR DETERMINING THERAPEUTIC ACTIVITY USING CONSTITUENT EXPRESSING ANIMALS OF G PROTEIN COUPLED RECEPTORS | |
TW200612906A (en) | Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |